drugset / Trial / NCT01197261

OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)

NCT01197261

Phase 2 Completed 120 enrolled Mundipharma Research GmbH & Co KG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study compares the analgesic efficacy of OXN PR vs placebo in opioid-naive subjects suffering from severe pain due to Bladder Pain Syndrome.

Timeline

Start
2010-09
Primary completion
2013-03
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naloxone Small molecule
Comparator Oxycodone Other / unclassified

Indications